What's New in Our Research
-
CD300ld on neutrophils is required for tumour-driven immune suppression
-
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial
The recommended first-line management of advanced
ovarian cancer comprises surgical staging and cytoreductive surgery followed by platinum-based chemotherapy. The
response rate for first-line platinum-based chemotherapy is ~80%, although ...
-
METTL3 regulates heterochromatin in mouse embryonic stem cells
METTL3 (methyltransferase-like 3) mediates the N6-methyladenosine (m6A) methylation of mRNA, which affects the stability of mRNA and its translation into protein. METTL3 also binds chromatin, but the role of METTL3 and m6A methylation in ch...
